CorMedix, Inc. (CRMD)
8.38
+0.12
(+1.45%)
USD |
NASDAQ |
Sep 01, 16:00
8.55
+0.17
(+2.03%)
Pre-Market: 08:10
CorMedix Free Cash Flow : 250.11M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 250.11M |
| March 31, 2026 | 194.58M |
| December 31, 2025 | 172.79M |
| September 30, 2025 | 74.42M |
| June 30, 2025 | 30.41M |
| March 31, 2025 | -13.63M |
| December 31, 2024 | -50.73M |
| September 30, 2024 | -56.15M |
| June 30, 2024 | -51.20M |
| March 31, 2024 | -45.70M |
| December 31, 2023 | -38.74M |
| September 30, 2023 | -33.98M |
| June 30, 2023 | -31.34M |
| March 31, 2023 | -28.24M |
| December 31, 2022 | -24.58M |
| September 30, 2022 | -24.79M |
| June 30, 2022 | -25.00M |
| March 31, 2022 | -22.63M |
| December 31, 2021 | -22.58M |
| September 30, 2021 | -22.09M |
| June 30, 2021 | -23.15M |
| March 31, 2021 | -20.81M |
| December 31, 2020 | -22.08M |
| September 30, 2020 | -20.19M |
| June 30, 2020 | -16.82M |
| Date | Value |
|---|---|
| March 31, 2020 | -15.91M |
| December 31, 2019 | -15.32M |
| September 30, 2019 | -18.39M |
| June 30, 2019 | -19.55M |
| March 31, 2019 | -24.04M |
| December 31, 2018 | -23.75M |
| September 30, 2018 | -23.95M |
| June 30, 2018 | -25.65M |
| March 31, 2018 | -29.07M |
| December 31, 2017 | -28.74M |
| September 30, 2017 | -27.84M |
| June 30, 2017 | -27.62M |
| March 31, 2017 | -23.63M |
| December 31, 2016 | -22.32M |
| September 30, 2016 | -19.46M |
| June 30, 2016 | -15.76M |
| March 31, 2016 | -15.59M |
| December 31, 2015 | -12.37M |
| September 30, 2015 | -10.31M |
| June 30, 2015 | -9.218M |
| March 31, 2015 | -7.367M |
| December 31, 2014 | -6.567M |
| September 30, 2014 | -5.889M |
| June 30, 2014 | -5.592M |
| March 31, 2014 | -4.403M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Innoviva, Inc. | 189.44M |
| Zevra Therapeutics, Inc. | 32.62M |
| Filana Therapeutics, Inc. | -29.30M |
| Eloxx Pharmaceuticals, Inc. | -- |
| Cannabis Global, Inc. | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 86.06M |
| Cash from Investing (Quarterly) | -0.561M |
| Cash from Financing (Quarterly) | -6.894M |
| Free Cash Flow Per Share (Quarterly) | 0.9245 |
| Free Cash Flow to Equity (Quarterly) | 85.23M |
| Free Cash Flow to Firm (Quarterly) | 85.50M |
| Free Cash Flow Yield | 32.65% |